LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Начало・Списък с акции・Cencora Inc

Cencora Inc

Затворен

СекторЗдравеопазване

361.95 -0.89

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

361.18

Максимум

368.2

Ключови измерители
By Trading Economics
Приходи	-28M 690M
Продажби	3.1B 84B
P/E Средно за сектора	45.868 105.69
EPS	3.84
Дивидентна доходност	0.61
Марж на печалбата	0.855
Служители	51,000
EBITDA	-1.1B 150M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+8.35% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.61% 2.37%
Следваща дата на дивидент	1.12.2025 г.
Следваща дата на екс-дивидент	14.11.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	4.6B 71B
Предишно отваряне	362.84
Предишно затваряне	361.95

Настроения в новините

By Acuity

45%

55%

157 / 374 Класиране в Healthcare

Cencora Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.11.2025 г., 21:34 ч. UTC

Печалби

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13.11.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13.11.2025 г., 23:42 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13.11.2025 г., 23:41 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13.11.2025 г., 23:24 ч. UTC

Печалби

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13.11.2025 г., 23:24 ч. UTC

Печалби

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13.11.2025 г., 23:23 ч. UTC

Печалби

JBS NV 3Q EPS 52c >JBS

13.11.2025 г., 23:23 ч. UTC

Печалби

JBS NV 3Q Sales $22.6B >JBS

13.11.2025 г., 23:04 ч. UTC

Пазарно говорене

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13.11.2025 г., 22:02 ч. UTC

Печалби

Nu Holdings 3Q Net $783M >NU

13.11.2025 г., 22:01 ч. UTC

Печалби

Nu Holdings 3Q Rev $4.2B >NU

13.11.2025 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13.11.2025 г., 21:50 ч. UTC

Печалби

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13.11.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13.11.2025 г., 21:41 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13.11.2025 г., 21:36 ч. UTC

Придобивния, сливания и поглъщания

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13.11.2025 г., 21:33 ч. UTC

Пазарно говорене

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13.11.2025 г., 21:33 ч. UTC

Печалби

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13.11.2025 г., 21:31 ч. UTC

Печалби

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13.11.2025 г., 21:25 ч. UTC

Печалби

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13.11.2025 г., 21:25 ч. UTC

Печалби

Figure Tech Solutions 3Q EPS 34c >FIGR

13.11.2025 г., 21:23 ч. UTC

Печалби

Intchains Group 3Q Rev $1.3M >ICG

13.11.2025 г., 21:03 ч. UTC

Печалби

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13.11.2025 г., 21:02 ч. UTC

Печалби

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13.11.2025 г., 21:01 ч. UTC

Печалби

Applied Materials 4Q Rev $6.8B >AMAT

13.11.2025 г., 21:01 ч. UTC

Печалби

Applied Materials 4Q Gross Margin 48.0% >AMAT

Сравнение с други в отрасъла

Ценова промяна

Cencora Inc Прогноза

Ценова цел

By TipRanks

8.35% нагоре

12-месечна прогноза

Среден 393.78 USD 8.35%

Висок 417 USD

Нисък 361 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Cencora Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

10 ratings

Купи

Задържане

Продай

Според 10 анализатори, дали борсови рейтинги на Cencora Inc през последните 3 месеца.

Настроение

By Acuity

157 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.